Evidence map›Paper›PMID 26190522›Full record

ArticleJournal of neurochemistry2015

Interferon gamma induces protective non-canonical signaling pathways in primary neurons.

Lauren A O'Donnell, Kristen M Henkins, Apurva Kulkarni, Christine M Matullo, Siddharth Balachandran, Anil K Pattisapu, Glenn F Rall

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Getting on your last nerve: IFNs and resistance to infection.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. mBio · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. The Interferon-Gamma Paradox in Cancer.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2019
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lauren A O'DonnellFox Chase Cancer Center, Program in Immune Cell Development and Host Defense, Philadelphia, Pennsylvania, USA.
Kristen M HenkinsFox Chase Cancer Center, Program in Immune Cell Development and Host Defense, Philadelphia, Pennsylvania, USA.
Apurva KulkarniDuquesne University, Mylan School of Pharmacy, Pittsburgh, Pennsylvania, USA.
Christine M MatulloFox Chase Cancer Center, Program in Immune Cell Development and Host Defense, Philadelphia, Pennsylvania, USA.
Siddharth BalachandranFox Chase Cancer Center, Program in Immune Cell Development and Host Defense, Philadelphia, Pennsylvania, USA.
Anil K PattisapuDuquesne University, Mylan School of Pharmacy, Pittsburgh, Pennsylvania, USA.
Glenn F RallFox Chase Cancer Center, Program in Immune Cell Development and Host Defense, Philadelphia, Pennsylvania, USA.
Fox Chase Cancer Center · USDuquesne University · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Pathogenesis of Neurotropic RNA Virus InfectionsR01NS040500 · NINDS · RESEARCH INST OF FOX CHASE CAN CTR · PI RALL, GLENN F · 2002 to 2006
$1.6M
Regulation and Relevance of Neuron-Specific Interferon Signaling PathwaysR56NS094475 · NINDS · RESEARCH INST OF FOX CHASE CAN CTR · PI RALL, GLENN F · 2016 to 2016
$443k
Mechanisms of cytokine-mediated viral clearance from neuronsF32NS062519 · NINDS · RESEARCH INST OF FOX CHASE CAN CTR · PI O'DONNELL, LAUREN ALENE · 2008 to 2010
$123k
NCI NIH HHS 5T32 CA 9035-38NCI NIH HHS P30 CA006927NCI NIH HHS P30CA006927NCI NIH HHS T32 CA009035NINDS NIH HHS F32 NS062519NINDS NIH HHS F32 NS062519-01NINDS NIH HHS R01 NS040500NINDS NIH HHS R01 NS40500NINDS NIH HHS R56 NS094475
6 · The paper itself

Abstract

The signal transduction molecule, Stat1, is critical for the expression of type I and II interferon (IFN)-responsive genes in most cells; however, we previously showed that primary hippocampal mouse neurons express low basal Stat1, with delayed and attenuated expression of IFN-responsive genes. Moreover, IFNγ-dependent resolution of a neurotropic viral challenge in permissive mice is Stat1-independent. Here, we show that exogenous IFNγ has no deleterious impact on neuronal viability, and staurosporine-induced apoptosis in neurons is significantly blunted by the addition of IFNγ, suggesting that IFNγ confers a pro-survival signal in neurons. To identify the pathways induced by IFNγ in neurons, the activation of alternative signal transducers associated with IFNγ signaling was assessed. Rapid and pronounced activation of extracellular signal regulated kinase (Erk1/2) was observed in neurons, compared to a modest response in fibroblasts. Moreover, the absence of Stat1 in primary fibroblasts led to enhanced Erk activation following IFNγ addition, implying that the cell-specific availability of signal transducers can diversify the cellular response following IFN engagement.

Indexed as

AnimalsAntimetabolitesBromodeoxyuridineCell SurvivalCytosolFemaleHippocampusInterferon-gammaMAP Kinase Signaling SystemMiceMice, TransgenicNeurogliaNeuronsNeuroprotective AgentsPregnancyPrimary Cell CultureAntimetabolitesBromodeoxyuridineInterferon-gammaNeuroprotective AgentsProtein Kinase InhibitorsStaurosporinecytokinesErk-1/2hippocampusInterferon gammaneuronStat1

Identifiers

PMID26190522
PMCPMC4809142
OpenAlexW2097826747

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.